Cargando…
Increased frequency of angina attacks caused by switching a brand-name vasodilator to a generic vasodilator in patients with vasospastic angina: Two case reports
It is well known that calcium channel blockers (CCBs) are the first line of therapy for vasospastic angina (VSA). Here, we report two cases of VSA with an increase in the frequency of angina attacks after switching from a brand-name to a generic CCB. In both cases, angina recurred upon switching fro...
Autores principales: | Goto-Semba, Remi, Fujii, Yuichi, Ueda, Tomohiro, Oshita, Chikage, Teragawa, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867450/ https://www.ncbi.nlm.nih.gov/pubmed/29588810 http://dx.doi.org/10.4330/wjc.v10.i3.15 |
Ejemplares similares
-
Clinical significance of prolonged chest pain in vasospastic angina
por: Teragawa, Hiroki, et al.
Publicado: (2020) -
Vasospastic Angina Diagnosed by the Spasm Provocation Test with the Combined Use of the Acetylcholine and Ergonovine Provocation Tests
por: Matsumura, Mirai, et al.
Publicado: (2019) -
Intracoronary Thrombogenicity in Patients with Vasospastic Angina: An Observation Using Coronary Angioscopy
por: Teragawa, Hiroki, et al.
Publicado: (2021) -
Vasospastic Angina in a Young Woman: A Case Report
por: Yoshida, Misa, et al.
Publicado: (2023) -
Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina
por: Lim, Yongwhan, et al.
Publicado: (2022)